8
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Methadone: A Bibliography, 1929-1971, Part 1

Pages 329-345 | Published online: 03 Jul 2009

References

  • Abreu B.E., et al. Effects of amphetamine, dihydro-ergotamine and methadon on human cerebral blood flow and oxygen up-take. Fed. Proc. 1948; 7(1)201
  • Adler T.K., Eisenbrandt L.L. The initial up-take of C14-labeled methadone by rat tissues. Proc. Soc. Exper. Biol & Med. 1949; 72: 347
  • Akera T., Brody T.M. The addiction cycle to narcotics in the rat and its relation to catecholamines. Biochem. Pharmacol. 1968; 17: 675
  • Alksne H., et al. A follow-up study of treated adolescent narcotic users. unpublished report of the Columbia University School of Public Health and Administrative Medicine, New York 1959
  • Alternatives to morphine. Brit. Med. J. 1966; 2(5521)1056
  • Althaus J.R., et al. Identification of the drug Darvon and its metabolites in the urine of a comatose patient using a gas chromatograph-mass spectrometer-computer system. Experientia 1970; 26(7)714
  • Angibeaud P., Buchel L., Levy J. Sur quelques phenomenes de synergie. I. Associations d'analgesiques et d'un spasmolytique considere comme leur analogue structural, (Some phenomena of synergism. 1. Association of an analgesic with a spasmolytic regarded as its structural analogue). C. R. Soc. Biol. (Paris) 1955; 149(34)258
  • Antweiler H. Biological detection of amidone abuse. Klin. Wschr. 1954; 32(5-6)138–39
  • Assouline G. Modifications et relations comportementales et electrocorticographiques provoquees chez le lapin par administration prolongee d'analgesiques morphiniques. Compt. Rend. Soc. Biol. 1966; 160(11)2171–76
  • Atanackovic D., De Jongh D.K. Action of methadone on blood pressure regulating mechanisms. Arch. Internal. Pharmacodyn. et de Therap. 1950; 82(4)494–98
  • Ausubel D.P. The Dole-Nyswander treatment of heroin addiction. J.A.M.A. 1966; 195(11)949–50
  • Bachelor A.L., Elliott H.W. The action of methadon upon the respiration of rat diaphragm and liver and kidney cortex slices. Fed. Proc. 1948; 7: 203
  • Batterman R.C. The importance of addiction to the newer synthetic analgesics in human therapy. Ann. New York Acad. Sci. 1948; 51(1)123–29
  • Batterman R.C., Oshlag A.M. The effectiveness and toxicity of methadon, a new analgesic agent. Anesthesiology 1949; 10(2)214–22
  • Bauer G., Ziegler E., Konzett H. Zur Hemmwirkung von Kininen an isolierten Darmpraeparaten. Arch. Pharmakol. Exper. Pathol. 1966; 254(3)235–44
  • Beaver W.T., et al. A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone. Clin. Pharmacol. Therap. 1967; 8(3)415–26
  • Beckett A.H. The importance of steric, stereochemical and physico-organic features in drug metabolism and drug action. Pure Appl. Chem. 1969; 19: 231–48
  • Beckett A.H., Casy A.F. Stereochemistry of certain analgesics. Nature 1954; 173(1447)1231–32
  • Beckett A.H., Moffat A.C. Routine detection and identification in urine of stimulants, analgesics, antihistamines, local anaesthetics and other drugs, some of which may be used to modify performance in sport. J. Pharm. Pharmacol. 1968; 20(12)48–50
  • Beckett A.H., et al. The biotransformation of methadone in man: Synthesis and identification of a major metabolite. J Pharm. Pharmacol. 1968; 20(10)754–62
  • Beecher H.K., et al. Field use of methadone and levo-iso-methadone in a combat zone. U.S. Armed Forces Med. J. 1951; 2(9)1269–76
  • Begany A.J., Seifter J. Studies on a heparin-like compound, algarin. Fed. Proc. 1948; 7: 206
  • Beleslin D.B., Bogdanovic S.B., Rakic M.M. Mechanism and site of action of methadone on the peristaltic reflex of the isolated guinea-pig ileum. Arch. Intern. Pharmacodyn. 1966; 164(2)345–55
  • Bentley K.W., Bower J.D., Lewis J.W. Novel analgesics and molecular rearrangements in the morphine-thebaine group. Part XVI. Some derivatives of 6, 14-endo-theno-7, 8-dihydromorphine. J. Chem. Soc. 1969; 18C: 2569–72
  • Berger H. Treatment of narcotic addicts in private practice. Arch. Intern. Med. 1964; 114: 59
  • Bewley T.H. The diagnosis and management of heroin addiction. Practitioner 1968; 200(1196)215–19
  • Bewley T.H., Ben Arie O. Physical dependence on heroin and pentobarbitone regimen for withdrawal. Practitioner 1968; 200(1196)251–53
  • Bleter R.N., Hirsh S.A. Methadone in internal medicine. Ann. New York Acad. Sci. 1948; 51: 137
  • Blachly P.H. Management of the opiate abstinence syndrome. Amer. J. Psychiat. 1966; 122: 742
  • Blachly P.H. Progress report on the methadone blockade treatment of heroin addicts in Portland. Northwest Med. 1970; 69: 172–76
  • Blane G.H. Oxygen consumption in the new-born rat and the effects of maternally administered analgesics. Brit. J. Pharmacol. 1967; 30(3)478–87
  • Blinick G. Menstrual function and pregnancy in narcotics addicts treated with methadone. Nature 1968; 219: 180
  • Blinick G., Wallach R.C., Jerez E. Pregnancy in narcotics addicts treated by medical withdrawal. The methadone detoxification program. Amer. J. Obstet. & Gynec. 1969; 105(7)997–1003
  • Bond J.M., et al. Irreversible corneal opacities produced in rats with high doses of dl-methadone HC1. Pharmacologist 1967; 9(2)231
  • Bonnycastle D.D., Leonard C.S. An estimation of the activity of analgetic materials. J. Pharmacol. 1950; 100(2)14145
  • Boyd E.M., Buell M. Methadone and respiratory tract fluid. Canad. Med. Assoc. J. 1950; 63(6)588–90
  • Brill L., Jaffe J.H. The relevance of some newer American treatment approaches for England. Brit. J. Addict. 1967; 62: 375–86
  • Broich J.R., De Mayo M.M., Dal Cortivo L.A. Separation and determination of opiates and diluents in illicit narcotic mixtures. J. Chromat. 1968; 33(3-4)526–29
  • Buchel L., Levy J., Tanguy O. Enhancement of the analgesic action of l-methadone by 5-hydroxytryptamine. C. R. Acad. Sci. 1958; 246(20)2947–49
  • Burks T.F., Long J.P. Release of gastrointestinal 5-hydroxytryptamine (5-HT) by morphine and related agents. Pharmacologist 1966; 8(2)216
  • Burks T.F., Long J.P. Release of gastrointestinal 5-hydroxytryptamine by morphine and related agents. J. Pharmacol. Exper. Therap. 1967; 156(2)267–76
  • Burks T.F., Long J.P. Responses of isolated dog small intestine to analgesic agents. J. Pharmacol. Exper. Therap. 1967; 158(2)264–71
  • Casy A.F., Hassan M.M.A. Catalytic hydrogenolysis of benzylmethyl- amino analogs of methadone and a-methadol. J. Med. Chem. 1969; 12: 337–39
  • Chappel C.I., Von Seemann C. Antitussive drugs. Progr. Med. Chem. 1963; 3: 89–145
  • Chapple P.A.L., Gray G. One year's work at a centre for the treatment of addicted patients. Lancet 1968; 1(7458)908–11
  • Chapple P.A.L., Gray G., Marks V. Treatment of heroin addiction. Lancet 1969; 1: 940, (May 3)
  • Chen K.K. Pharmacology of methadone and related compounds. Ann. New York Acad. Sci. 1948; 51(1)83–97
  • Chernov H.I., et al. Non-specificity of the mouse writhing test. Arch. Intern. Pharmacodyn. 1967; 167(1)171–78
  • Cochin J. Analysis for narcotic analgesics and barbiturates in urine by thin-layer chromatographic techniques without previous extraction and concentration. Psychopharmacol. Service Center Bull. 1966; 3(4)53–60
  • Cochin J., et al. Further observations on addiction of methadone in the monkey. Proc. Soc. Exper. Biol. Med. 1948; 69: 430
  • Coen R.W., Light I.J., Sutherland J.M. Methadone substitution in neonatal narcotic withdrawal. Seventy-Ninth Annual Meeting, The American Pediatric Society. April 30 to May 3, 1969
  • Collins R.J., Weeks J.R. Relative potency of codeine, methadone and dihydromorphinone to morphine in self-maintained addict rats. Arch. Exper. Pathol. Pharmacol. 1965; 249(6)509–14
  • Collins R.J., Weeks J.R., Macgregor D.W. An attempt to demonstrate ceiling efficacy of analgesics in rats. Arch. Intern. Pharmacodyn. 1964; 147(1-2)76
  • Cox B.M., Weinstock M. Quantitative studies of the antagonism by nalorphine of some of the actions of morphine-like analgesic drugs. Brit. J. Pharmacol. 1964; 22: 289–300
  • Crema A., et al. The responses of the terminal bile duct to morphine and morphine-like drugs. J. Pharmacol. Exper. Therap. 1965; 149(3)373–78
  • Cushman P., Bordier B., Hilton J.G. Hypothalmic-pituitary-adrenal axis in methadone-treated heroin addicts. J. Clin. Endocrinol. Metabol. 1970; 30: 24–29, (January)
  • Deffenu G., Pegrassi L., Lumachi B. The use of Bradykinin-induced effects in rats as an assay for analgesic drugs. J. Pharm. Pharmacol. 1966; 18(2)135
  • Denton J.E., Beecher H.E. New analgesics, II, and III. J.A.M.A. 1949; 141: 1146
  • Denton J.E., et al. A comparison of side-actions and analgesic effects of morphine, amidone, (4-4-diphenyl-6-diinethylarnino-heptanone-3) and its isomers in man. Fed. Proc. 1948; 7: 214
  • Dole V.P. Thoughts on narcotics addiction. Bull. New York Acad. Sci. 1965; 41(2)211–13
  • Dole V.P., Kim W.K., Eglitis I. Detection of narcotic drugs, tranquilizers, amphetamines, and barbiturates in urine. J.A.M.A. 1966; 198(4)349–52
  • Dole V.P., Kim W.K., Eglitis I. Extraction of narcotic drugs, tranquilizers, and barbiturates by cation-exchange paper and detection on a thin-layer chromatogram by a series of reagents. Psychopharmacol. Service Center Bull. 1966; 3(4)45–48
  • Dole V.P., Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. J.A.M.A. August 23, 1965; 193(8)646
  • Dole V.P., Nyswander M. Heroin addiction-A metabolic disease. Arch. Int. Med. 1967; 120: 19–24
  • Dole V.P., Nyswander M. Methadone maintenance and its implications for theories of narcotic addiction. Assoc. Res. Nerv. & Ment. Dis. 1966; 46: 359
  • Dole V.P., Nyswander M. Rehabilitation of heroin addicts after blockade with methadone. New York State J. Med. August 1, 1966; 66: 2011
  • Dole V.P., Nyswander M. Rehabilitation of the street addict. Arch. Environ. Health 1967; 14: 477–80
  • Dole V.P., Nyswander M. Study of methadone as an adjunct in rehabilitation of heroin addicts. Illinois Med. J. 1966; 130: 487–89
  • Dole V.P., Nyswander M. The treatment of heroin addiction. J.A.M.A. 1966; 195: 972
  • Dole V.P., Nyswander M. The use of methadone for narcotic blockade. Brit. J. Addict. 1968; 63: 55–57
  • Dole V.P., Nyswander M., Kreek M.J. Narcotic blockade (original article). Arch. Int. Med. 1966; 118: 304–09
  • Dole V.P., Nyswander M., Kreek M.J. Narcotic blockade-A medical treatment for stopping heroin use by addicts. Tr. A. Am. Physicians 1966; 79: 122–35
  • Dole V.P., Nyswander M., Warner A. Successful treatment of 750 criminal addicts. J.A.M.A. 1968; 206: 2708–11
  • Dole V.P., Warner A. Evaluation of narcotics treatment program. Amcr. J. Public Health 1967; 57(11)2000–08
  • Dole V.P., et al. Methadone treatment of randomly selected criminal addicts. New England J. Med. 1969; 280: 1372–75
  • Dundee J.W., Clarke R.S.J., Loan W.B. Comparative toxicity of diamorphine, morphine, and methadone. Lancet July 29, 1967; 2: 7509
  • Duvall H.J., Locke B.Z., Brill L. Follow-up study of narcotic drug addicts five years after hospitalization. Public Health Reports March, 1963; 78(3)185–93
  • Eadie G.S., Bernheim F., Fitzgerald D.B. The effect of methadon on the cholinesterase of the brain. Brit. J. Addict. 1968; 63: 55–57
  • Eadie G.S., Bernheim F., Fitzgerald D.B. The inhibition of the cholinesterase of rat brain by methadon. J. Pharmacol. Exper. Thcrap. 1948; 94(1)19–21
  • Easton N.R., Gardner J.H., Stevens J.R. A new synthesis and confirmation of the structure of amidone. J. Amer. Chem. Soc. 1947; 69(12)2941
  • Easton N.R., et al. Some isomers of amidone and related compounds. J. Amer. Chem. Soc. 1948; 70: 76
  • Eddy N.B. A new morphine-like analgesic. J. Amer. Pharm. Assoc. 1947; 8(11)536–40
  • Eddy N.B. Newer narcotics. Amer. Prac. 1948; 3(l)37–42
  • Eddy N.B. The use of drugs in the management of drug dependence. J. Tennessee Med. Assoc. 1967; 60: 269–73
  • Eddy N.B., et al. Codeine and its alternates for pain and cough relief. 3. The antitussive action of codeine-mechanism, methodology and evaluation. Bull. Wld. Health Organ. 1969; 40(3)425–54
  • Eddy N.B., et al. Codeine and its alternates for pain and cough relief. 4. Potential alternates for cough relief. 5. Discussion and summary. Bull. Wld. Health Organ. 1969; 40(5)639–730
  • Eddy N.B., et al. Drug dependence: Its significance and characteristics. Bull. Wld. Health Organ. 1965; 32: 721–33
  • Edwards G. Relevance of American experience of narcotic addiction to the British scene. Brit. Med. J. 1967; 3: 425–29
  • Eisenbrandt L.L., Elliott H.W. Comparative in vivo and in vitro effects of methadone upon the QO2 of rat liver, kidney and jejunum. J. Pharmacol. Exper. Therap. 1949; 97(1)120–24
  • Eisenbrandt L.L., et al. The role of the gastro-intestinal tract in the excretion of C14-labeled methadone by rats. J. Pharmacol. Exper. Thcrap. 1950; 98(2)200–05
  • Elliot H.W., Abdel-Rahman M.A. Cardiovascular actions of narcotic analgesics. Amer. Heart J. 1965; 69: 567–68
  • Elliot H.W., Elison C. Influence of some adrenal and pituitary hormones on the absorption and biological disposition of methadone. J. Pharmacol. Exper. Therap. 1961; 131(1)31–37
  • Elliot H.W., Sutherland V.C. Influence of methadone on oxygen uptake and glycogenosis of rat liver slices. Proc. Soc. Exp. Biol. 1950; 75(1)242–44
  • Elliot H.W., Warrens A.E., James H.P. Some effects of l-methyl-4-phenyl ethyl isonipecotate (Demerol) and 6-dimethylamino-4,4-diphenyl-3-heptanone (Amidone) upon the metabolism of rat brain tissue in vitro. J. Pharmacol. Exper. Therap. 1947; 91(2)98–102
  • Elliott H.W., et al. Comparison of the nalorphine test and urinary analysis in the detection of narcotic use. Clin. Pharmacol. Therap. 1964; 5(4)405–13
  • Elliott H.W., et al. The distribution of radioactivity in rats after administration of C14-labeled methadone. J. Pharmacol. Exper. Therap. 1949; 95(4)494–501
  • Emmerson J.L., Anderson R.C. A method for the thin-layer chromato- graphy of analgesic drugs and related compounds in non-aqueous systems. J. Chromatog. 1965; 17: 495–500
  • Ettinger M.J., Gero A. Interactions of narcotics and their antagonists with human serum esterase. Pharmacologist 1965; 7(2)164
  • Ettinger M.J., Gero A. Interactions of narcotics and their antagonists with human serum esterase. I. Sites of action and nature of the inhibitory effect. II. Nature of the antagonism. Arch. Intern. Pharmacodyn. 1966; 164(1)96–119
  • Everett F.G. The local anesthetic properties of amidone (Dolophine). Anesthesiology 1948; 9: 115
  • Finnegan J.K., et al. Observations on the comparative pharmacologic actions of 6-dimethylamino-4,4-diphenyl-3-heptanone (amidone) and morphine. J. Pharm. Exper. Therap. 1948; 94: 269
  • Fraser H.F., Grider J.A., jr. Treatment of drug addiction. Amer. J. Med. 1953; 14(5)571–77
  • Fraser H.F., et al. Methods for evaluating addiction liability. (A) “Attitude” of opiate addicts toward opiate-like drugs, (B) A short-term “direct” addiction test. J. Pharmacol. Exper. Therap. 1961; 133(3)371–87
  • Fraser HF., et al. Use of n-allylnormorphine in treatment of methadone poisoning in man. J.A.M.A. 1952; 148: 1205
  • Freedman A.M. Drug addiction: An eclectic view. J.A.M.A. 1966; 197: 878–82
  • Freedman A.M., et al. Cyclazocine and methadone in narcotic addiction. J.A.M.A. 1967; 202: 191–94
  • Frenkel M. Pijnbestrijding bij kanker. Ned. Tijdschr. Geneesk. 1968; 112(1)18–22
  • Freymuth H.W. Methadone and the private practitioner. J. Med. Soc. New Jersey March, 1970; 67: 128–30
  • Friend D.G. Accidental therapeutic drug addiction. Clin. Pharamacol. Therap. 1966; 7(6)832–34
  • Gaarenstroom J.H. De keuze van een pijnstillend middel. Ned. Tijdschr. Geneesk. 1965; 109(14)64142
  • Gadeke R. Evaluation of the central analgetic 6-dimethylamino-4; 4-diphenyl-3- heptanone ('methadone,' 'polamidone' etc.). Med. Mschr. 1952; 6(4)214–18
  • Gasser G. Tierexperimentelle Untersuchunger ueber die Hamproduktion bei erhoehtem Druck in den ableitenden Harnwegen. Wien. Klin. Wschr. 1967; 79(16)289–94
  • Gearing F.R., et al. Methadone maintenance treatment program, progress report of evaluation; submitted to New York State Narcotics Addiction Control Commission. March 31, 1970
  • Geber W.F., Schramm L.C. Comparative teratogenicity of morphine, heroin and methadone in the hamster. Pharmacologist 1969; 11(2)248
  • Genovese E., et al. Metodo per la Misurazione deH'Attivita' Analgesica nel Ratto.fiotf. Soc. Hal. Biol. Sper. 1968; 43(23)17, 19-23
  • Gentling A.A., Lundy J.S. A new analgesic, AN-148. preliminary report. Proceedings of the Staff Meetings of the Mayo Clinic 1947; 22(13)249–51
  • Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics Ed. 4. The Macmillan Company, New York 1970; 260
  • Gordon N.B. Reaction-times of methadone treated ex-heroin addicts. Psycho- pharmacologia 1970; 16: 337–44
  • Greig M.E. The inhibition of hexokinase by amidone (2-dimethyl-amino-4,4-diphenylheptanone-5-hydrochloride). Arch. Biochem. 1948; 17: 129
  • Greig M.E., Gibbons A.J. Action of some centrally acting drugs on ion transport in red cells. Science 1956; 123(3204)939–40
  • Greig M.E., Howell R.S. The inhibition by amidone of pyruvate and succinate oxidation by rat brain and the reversal of the inhibition by boiled yeast extract. Arch. Biochem. 1948; 19(3)441–48
  • Grumbach L., Chernov H.I. The analgesic effect of opiate-opiate antagonist combinations in the rat. J. Pharmacol. Exper. Therap. 1965; 149(3)385–96
  • Guiffrida J.G., et al. Anesthetic management of drug abusers. Anesthesia Analg. 1970; 49: 272–78
  • Gunne L.M. Treatment of drug addiction with narcotic blockade. Lakartidningen 1966; 63: 4060–64
  • Gupta G.N. Thin-layer chromatography in disposable plastic bags for radioactive and non-radioactive substances. J. Chromatog. 1969; 41(3-4)467–70
  • Haag H.B., Finnegan J.K., Larson P.S. Pharmacologic observations of 1,1-diphenyl-1-(dimethyl-aminoisopropyl)-butanone-2. Fed. Proc. 1947; 6: 334
  • Haas H. Comparative studies on analgesics. Arch. Exper. Path. Pharmak. 1950; 212(1-2)162–63
  • Haas H. Vom Arzneimittel aus Pflanzen zum Synthetischen Arzneimittel. Med. Welt. 1967; 41: 2406–07
  • Haas H., Hohagen E., Kollmannsperger G. Comparative study of analgesics. Arzneimittel-Forsch. 1953; 3(5)238–47
  • Haensel R. Zur Pharmakologie des Schmerzes. Arch. Pharm. 1966; 299(2)40–41
  • Haffner F. Experimentelle Prufung Schmerzstillender Mittel. Duetsche med. Wchnschr. 1929; 55: 731
  • Haldane F.P. Systemic infections in heroin addicts. Lancet 1968; 1(7533)95
  • Harder H.J., Leutner V. Morphin-Antagonisten, quantum et quando? Ueberdosierung ein Beitrag zur dosisgerechten und gezielten Antidot-behandlung. Anaesthesist 1966; 15(8)279–83
  • Hawes A.J. Goodbye junkies. Lancet August 1, 1970; 2: 258
  • Heaton A.M., Blumberg A.G. Thin-layer chromatographic detection of barbiturates, narcotics and amphetamines in urine of patients receiving psychotropic drugs. J. Chromatog. 1969; 41(3-4)367–70
  • Hebb C.O., Konzett H. Difference between morphine and synthetic analgesics in their actions on ganglionic transmission. Nature 1949; 163(4149)720–21
  • Helpern M., Rho Y. Deaths from narcotism in New York City. New York S. J. Med. 1966; 66(18)2391–2408
  • Henderson F.G., Chen K.K. Effect of age upon toxicity of methadon. Proc. Soc. Exper. Biol. & Med. 1948; 68: 350
  • Heroin and the new prescribers. Brit. Med. J. 1968; 1(5594)719–20
  • Herr F., Perszasz J. A new method for the testing of analgetic effect. Arch. Exper. Pathol. 1950; 210(3)289–93
  • Hildebrandt F., Matthay E. Action of the powerful analgetics amidone, amidone plus diphenylpiperidinoacetamide ('Polamivet') and 3-hydroxy-n-methylmorphinan on intestinal motility. Arch. Exper. Path. Pharmak. 1954; 221(5)399–403
  • Hill H.E., et al. Comparative effects of methadone, meperidine and morphine on conditioned suppression. Arch. Intern. Pharmacodyn. 1966; 163(2)341–52
  • Hoffman F. Drug addiction and logic. J.A.M.A. 1967; 201(6)491–92
  • Hoffman L. A methadone program for addicts with chest disease. J.A.M.A. 1970; 211(6)977–82
  • Hoffman L., et al. Methadone in the treatment of tuberculous heroin addicts. Clin Res. 1968; 16: 366
  • Hoffmann G., Kempe D. Spasmolytic action of some analgesics on the smooth musculature of the intestine and blood vessels. Klin. Wschr. 1951; 29(19-20)349–51
  • Hoppe J.O., Miller L.C. A comparison of the toxicity of methadon and some related compounds. Fed. Proc. 1948; 7: 228
  • Hubach C.E., Jones F.T. Methadon hydrochloride. Optical properties, microchemical reactions, and X-ray diffraction data. Analyt. Chem. 1950; 22(4)595–98
  • Hunter A.R., Pleuvry B.J., Rees J.M.H. The respiratory depressant effects of barbiturates and narcotic analgesics in the unanesthetized rabbit. Brit. J. Anaesth. 1968; 40(12)927–35
  • Inturrisi C.E., Fujimoto J.M. The antidiuretic effect of narcotic analgesics in the mouse. Toxocol. Appl. Pharmacol. 1968; 13(2)251–57
  • Irwin S., et al. The effects of morphine, methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation. J. Pharmacol. 1951; 101(2)132–43
  • Is narcotic addiction a chronic disease?. J. Chron. Dis. 1966; 19: 949–51
  • Isaac R.H., Nyswander M. Points raised on methadone. Amer. J. Psychiat. 1967; 124(4)570–71
  • Isbell H. Management of self-identified codeine addict. JAMA 1969; 209(10)1533
  • Isbell H., Vogel V.H. The addiction liability of methadon, (amidone, Dolophine, 10820) and its use in the treatment of the morphine abstinence syndrome. Amer. J. Psychiat. 1949; 105: 909
  • Isbell H., et al. Effect of single doses of 10820 (4-4-diphenyl-6-dimethylamino- heptanone-3) on man. Fed. Proc. 1947; 6: 341
  • Isbell H., et al. Experimental addiction to 10820 (44-diphenyl-6-dimethyl- amino-heptanone-3) in man. Fed. Proc 1947; 6: 264
  • Isbell H., et al. Liability of addiction of 6-dimethyl-amino-4-4-diphenyl-3-heptanone (methadon, “amidone,” or “10820”) in man. Experimental addiction to methadone. Arch. Int. Med. 1948; 82: 362
  • Isbell H., et al. The effects of single doses of 6-dimethylamino-4-4-diphenyl-3- heptanone (Amidone, methadone, or '10820') on human subjects. J. Pharmacol. Exper. Therap. 1948; 92: 83
  • Isbell H., et al. Tolerance and addiction liability of 6-dimethylamino-4-4- diphenyl-heptanone-3 (methadone). JAM.A. 1947; 135: 888
  • Isbell H., et al. Treatment of the morphine abstinence syndrome with 10820 (4-4-diphenyl-6-dimethylamino-heptanone-3). Fed. Proc. 1947; 6: 340
  • Ishmael W.K., Stacy J.R. The use of Dolophine (dimethylamino heptanone-methadon) in the control of pain in bone and joint disorders. J. Oklahoma Med. Assoc. 1947; 40: 454
  • Jaffe J.H., et al. Comparison of acetylmethadol and methadone in the treatment of long-term heroin users. JAMA March 16, 1970; 211(11)1834
  • Jaffe J.H., et al. Comparison of dl-alpha-acetyl methadol and methadone in the treatment of narcotics addicts. Pharmacologist 1969; 11(2)256
  • Jaffe J.H., Kirkpatrick D. The use of ion-exchange resin impregnated paper in the detection of opiate alkaloids, amphetamines, phenothiazines and barbiturates in urine. Psychopharmacol. Service Center Bull. 1966; 3(4)49–52
  • James H.P., Page E.W. Influence on some analgetics of obstetrical importance upon respiration of mature human placenta in vitro. Fed. Proc. 1948; 7: 230
  • Jenney E.H., Pfeiffer C.C. Comparative analgesic and toxic effects of the optical isomers of methadon and isomethadon. Fed. Proc. 1948; 7: 231
  • Johnson C.A., King R.E. A direct titrimetric method for the deter- mination of some organic bases in pharmaceutical preparations. J. Pharm. Pharmacol. 1963; 15: 584–88
  • Karr N.W. Effects of 6-dimethylamino-4,4-diphenyl-3-heptanone (Dolophine) on intestinal motility. Fed. Proc. 1946; 6: 343
  • Kirchhof A.C., David N.A. A clinical trial of a new synthetic heptanone analgesic (Dolophine). I. Preliminary Report. West. J. Surg. Obstet. & Gynec. 1947; 55: 183
  • Kirchhof A.C., David N.A. Clinical trial of 6-dimethylamino-4,4-di-phenyl-3-heptanone (Dolophine) a synthetic analgesic. Fed. Proc. 1947; 6: 345
  • Knoll J., Komlos E., Tardos L. Role of protein-binding in the synergism of analgetics and cholinergic agents. Acta Physiol. Acad. Sci. Hungary 1953; 4(1-2)131–40
  • Konzett H., Bauer H. Zur Charakterisierung der Bradykinin-Wirkung auf dieglatte Muskulatur. Z. Physiol. Chem. 1968; 349(7)927–28
  • Kuntze A. Neuroleptanalgesia. Vet. Rec. 1967; 80(8)278–80
  • Kupferberg H.J., Burkhalter A., Way E.L. Fluorometric identification of sub-microgram amounts of morphine and related compounds on thin-layer chromatographs. J. Chromatog. 1964; 16: 558–59
  • Lambert A., et al. Report of the Mayor's Committee on Drug Addiction to the Honorable R.C. Patterson, Jr., commissioner of Correction, New York City. Amer. J. Psychiat. November, 1930; 10(3)433–538
  • Lapierre J. Possible hepatotoxic effect of methadone. Canad. Med. Assoc. Jr. 1969; 101: 113
  • Lasagna L. The clinical evaluation of morphine and its substitutes as analgesics. Pharmacol. Rev. March, 1964; 16: 47–83
  • Leimdorfer A. An electroencephalographic analysis of the action of amidone, morphine, and strychnine on the central nervous system. Arch. Int. Pharmacodyn. 1948; 76: 153
  • Leimdorfer A. Influence of amidone, morphine, and strychinine on the Straub-tail test of white mice. Fed. Proc. 1948; 7: 239
  • Lewis J.R. The development of tolerance in rats to some new synthetic analgesics. J. Pharmacol. Exper. Therap. 1949; 96(1)31–37
  • Loan W.B., Dundee J.W. The value of the study of postoperative pain in the assessment of analgesics. Brit. J. Anaesth. 1967; 39(9)743–50
  • Longo V.G., Napolitano L. Action of analgesic drugs (morphine, meperidine, methadone) on rotatory nystagmus in the rabbit. J. Pharmacol. 1953; 107(2)154–59
  • Lorenzetti O.J., Sancilio L.F. Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds. Arch. Intern. Pharmacodyn. 1970; 183: 391–402
  • Lorenzetti O.J., Sancilio L.F. Usefulness of morphine addicted rats in estimating addiction liability. Pharmacologist 1966; 8(2)206
  • Louria D.B. Medical complications associated with heroin use. Internal. J. Addict. 1967; 2(2)241–51
  • Louria D.B., Hensle T. The major medical complications of heroin addiction. Ann. Int. Med. 1967; 67(1)1–22
  • Luckner H., Magun R. A method of quantitative testing of analgesic effects in naimal study. Z. ges. exp. Med. 1951; 117(2)133–45
  • Luduena F.P., Ananenko E. The pharmacodynamic effects of some new analgesics. Arch. Internal, de Pharmacodyn. et Therap. 1950; 81(3)259–75
  • Luduena F.P., et al. Some pharmacological actions of isomers of methadon. Fed. Proc. 1948; 7: 241
  • Maddux J.F. Current approaches to the treatment of narcotic addiction. J. Nat. Med. Assoc. 1969; 69: 248
  • Management of narcotic-drug dependence of high-dosage methadone HCl technique. Dole-Nyswander program. J.A.M.A. 1967; 201(12)956–57
  • Mandy S., Ackerman A.B. Characteristic traumatic skin lesions in drug-induced coma. J.A.M.A. 1970; 213: 253–56
  • Marshall I., Weinstock M. A quantitative method for the assessment of physical dependence on narcotic analgesics in mice. Brit. J. Pharmacol. 1969; 37(2)505P–56P
  • Matts S.G.F., Swan C.H.J., Wharton B.A. Double blind trial of dextromoramide, methadone and pethidine in the treatment of severe pain. Postgrad. Med. J. 1964; 40: 103
  • McCurley W.S., Tunnessen WW., Jr. Methadone toxicity in a child. Pediatrics 1969; 43(1)90–92
  • McMahon R.E., Culp H.W., Marshall F.J. The metabolism of a-dl-acetylmethadol in the rat: The identification of the probable active metabolite. J. Pharm. Exper. Therap. 1965; 149: 436
  • McMartin C., Simpson P., Thorpe N. The specific assay of basic drugs in urine by CM-cellulose chromatography using continuous drug-dye complex extraction as a detection system. J. Chromatog. 1969; 43(1)72–83
  • Medical treatment of addiction. New York Acad. Sci. 1969; 9: 11
  • Merry J. Assessing heroin addiction. Lancet 1968; 1(7536)244
  • Methadone clinical trials under study. J.A.M.A. April 14, 1969; 208(2)251–52
  • Methadone in the management of opiate addiction. Medical Letter November 28, 1969; 11(24)97
  • Methadone maintenance for heroin addiction. Yale Law J. 1969; 78: 1175–1211
  • Methadone management of heroin addiction. Bull. New York Acad. Med. June, 1970; 46: 391–95
  • Methadone replacement on the way?. J.A.M.A. September 15, 1969; 209(10)1627
  • Methadone treatment of randomly selected criminal addicts. New England J. Med. 1969; 280(25)1372–75
  • Miller J.W., Elliott H.W. In vitro studies on the diphasic action of methadone. J. Pharmacol. Exper. Therap. 1954; 110: 106–14
  • Miller J.W., Elliott H.W. Rat tissue levels of carbon-14 labeled analgetics as related to pharmacological activity. J. Pharmacol. 1955; 113(3)283–91
  • Milosevic M.P. The analgesic activity of sympathomimetic amines. Acta. Med. Iugosl. 1958; 12(1-2)111–19
  • Milosevic M.P. The effect of sympathomimetic amines on pain sensitivity. Acta. Med. Iugoslav. 1956; 10(3)280–88
  • Monitoring the mainliner. Lab. Manag. August, 1969; 7: 30–31
  • Molinengo L., Ricci-Gamalero S. Action of codeine, pethidine, and methadone on the operant behavior of the rat. Psychopharmacologia 1970; 17: 34–48
  • Montalvo J.G., et al. Identification of drugs of abuse in urine. J. Chromatog. 1970; 47: 542–45
  • Myerson D.J. Methadone treatment of addicts. New England J Med. August 14, 1969; 281: 390–91
  • Nahum L.H. The methadone treatment for the criminal addict. Connecticut Med. J. August, 1969; 33: 504
  • Narcotics and medical practice—medical use of morphine and morphine-like drugs and management of persons dependent on them. J.A.M.A. 1967; 202: 209–12
  • Van Der Nat J. Hyperpyrexie tijdens narcose. Ned. Tijdschr. Geneesk. 1968; 112(49)2227–29
  • Nelson A.S. Medical problems associated with addiction to opioid drugs. Internat. J. Addict. 1966; 1: 50–61
  • Neudek K. Entziehungsprogramm fuer Rauschgiftsuechtige in den USA. Muench. Med. Wochenschr. 1970; 112(22)1054–56
  • Nilsson E. On treatment of barbiturate poisoning. Acta Med. Scandinav. 1951; 140(Supplement)1
  • Nix J.T. Control program for heroin addiction. J.A.M.A. February 23, 1970; 211: 1378
  • Nix J.T. Methadone for narcotics addicts. J.A.M.A. March 31, 1969; 207: 2439
  • Noirfalise A., Mees G. Chromatographic sur couche mince de quelques alcaloides et bases aminees.7. Chromatog. 1967; 31(2)594–97
  • Nyswander M. From drug addict to patient. NYSDB Bull 1967; 5, (June)
  • Nyswander M., Dole V.P. The present status of methadone blockade treatment. Amer. J. Psychiat. 1967; 123(11)1441–42
  • O'Donnell J.A. A follow-up of narcotics addicts. Amer. J. Orthopsychiatry October, 1964; 34(4)948–54
  • Ofner P., Walton E. Search for new analgesics. IV. Variations in the basic side-chain of amidone. J. Chem. Soc. 1950; 2158–2166, (1975-2257)
  • Ono M., Engelke B.F., Fulton C. Procedures for assured identification of morphine, dihydromorphinone, codeine, norcodeine, methadone, quinine, methamphetamine, etc., IN human urine. Bull. Stupefiants 1969; 21(2)31–40
  • Orahovats P.D., Lehman E.G., Chapin E.W. Potentiating effects of quinine. I. Analgesics and hypnotics. Arch. Int. Pharmacodyn. 1957; 110(2-3)245–58
  • Palosi E., Szporny L. New, simple method for the informative investigation of sedatives. Psychopharmacologia 1967; 12(1)44–49
  • Parbrook G.D. Post-operative pain relief: Comparison of methadone and morphine when used concurrently with nitrous-oxide analgesia. Brit. Med. J. 1966; 2(5514)616–18
  • Parker K.D., Hine C.H. Manual for the determination of narcotics and dangerous drugs in the urine. Psychopharmacol. Service Center Bull. 1966; 3(3)18–42
  • Parker K.D., et al. Urine screening techniques employed in the detection of users of narcotics and their correlation with the nalorphine test. J. Forensic Sci. 1966; 11: 152–66
  • Paulus I., Halliday R. Rehabilitation and the narcotic addict: Results of a comparative methadone withdrawal program. Canad. Med. Assoc. J. 1967; 96: 655
  • Pearl J., Aceto M.D., Harris L.S. Prevention of writhing and other effects of narcotics and narcotic antagonists in mice. J. Pharmacol. Exper. Therap. 1968; 160(1)217–30
  • Perkins M.E., Bloch H.I. A study of some failures in methadone treatment; presented at the 123rd annual meeting of the American Psychiatric Association, San Francisco, California, May 11-15, 1970
  • Perkins M.E., Bloch H.I. Survey of methadone maintenance treatment program. Amer. J. Psychiat. April, 1970; 125: 1389–96
  • Pfeiffer C.C., et al. Experimental methods for studying analgesia. Ann. New York Acad. Sci. 1948; 51(1)21–33
  • Pfeiffer C.C., Santos-Martinez J., Sherrod T.R. The nature of the prosthetic groups of analgesics and their possible action as blocking agents. Fed. Proc. 1948; 7: 248
  • Phatak N.M., David N.A. Addiction potentialities of some methadone analgesics and alpha-acetyl-methadol as determined by their hyperglycemic responses in rabbits. Curr. Res. Anesth. 1953; 32(4)242–49
  • Pohland A., Marshall F.J., Carney T.P. Optically active com- pounds related to methadon.J. Med. Chem. 1949; 71: 460
  • Popkin R.J. Experiences with a new synthetic analgesic, Amidone: Its action on ischemic pains of occlusive arterial disease. Amer. Heart J. 1948; 35: 793
  • Portoghese P.S. Stereochemical factors and receptor interactions associated with narcotic analgesics. J. Pharm. Sci. 1966; 55(9)865
  • Portoghese P.S., Williams D.A. Stereochemical studies on medicinal agents. VII. Absolute stereochemistry of methadol isomers and the role of the 6-methyl group in analgetic activity. J. Med. Chem. 1969; 12: 839–44
  • Portoghese P.S., Williams D.A. Stereochemistry of methadol diaster- eomers. J. Pharm. Sci. 1966; 55: 990–01
  • Powell C.E., Chen K.K. Action of Dolophine on the animal uterus. J. Amer. Pharm. Assoc. 1948; 37: 516
  • Powers B.R. Use of methadone to combat withdrawal symptoms of “Dilaudid” addiction: Case report. J. Tennessee Med. Assoc. 1949; 42: 83
  • Progress report of evaluation of methadone maintenance treatment program as of March 31, 1968. J.A.M.A. 1968; 206: 2712–14
  • Quijada L., Contreras E., Tamayo L. Antagonistic action of tolazoline upon the analgesic effect of some morphine analogues. Med. Exp. 1967; 16(3)190–92
  • Raskin H.A. Rehabilitation of the narcotic addict. J.A.M.A. September 12, 1964; 189(12)180–82
  • Remy D., Wolsky H. Effect of methadone, in comparison with that of morphine and of isonipecaine, on ventilation capacity with carbon dioxide breathing. Therapie der Gegenwart 1950; 2: 41–46
  • Rice J., Cohen L. Narcotic drug addiction: One year's experiences at Pilgrim State Hospital. Psychiat. Quart. July, 1965; 39: 457–65
  • Rickards J.C., et al. Studies on the distribution and metabolism of methadone in normal and tolerant rats by a new colorimetric method. J. Pharmacol. Exper. Therap. 1950; 98: 380–91
  • Roubicek J., Zaks A., Freedman A.M. EEG changes produced by heroin and methadone. Electroenceph. Clin. Neurophysiol. 1969; 27: 667
  • Roxburgh R.C., Munro-Faure D. Amidone overdosage in a child. Lancet 1951; 1: 174
  • Ruemmler R., Haller R. Chromatographic methods for the separation of methadone and its reduction products, α- and β-methadol. Arzneim. Forsch. 1970; 20: 281–82
  • Sander M. Chemistry and analgetic activity of basic l:l-diphenylalkane derivatives. Arzneim. Forsch. 1954; 4(3)183–89, 4(4):257;4(6):375-80
  • Sapira J.D., et al. Addiction to methadone among patients at Lexington and Fort Worth. Public Health Reports August, 1968; 83(8)691–94
  • Schaumann O., Lindner E. New synthetic compounds of the “polamidone series” with anticholinergic action. Arch. Exp. Path. U. Pharmakol. 1951; 211(1)93–102
  • Schaumann W. Effects of morphine-like analgetics on the guinea-pig ileum in situ. Arch. Exp. Path. U. Pharmakol. 1954; 223(4)348–54
  • Schneider K.W. Behandlung des Herzinfarktes in der Praxis (Soforttherapie und Langzeitbehandlung). Med. Klin. 1966; 61(41)1616
  • Schneider K.W. Klinik und Therapie der Koronarinsuffizienz. Med. Mschr. 1967; 21(10)439–43
  • Schneider K.W. Behandlung des Herzinfarktes in der Praxis Soforttherapie und Langzeitbehandlung. Therapiewoche 1967; 17(13)396403
  • Schoolar J.C., Idanpaan H.P., Keats A.S. Pentazocine addiction. Lancet 1969; 1(7608)1263
  • Schueller F.W., Gross E.G. Effect of two new analgetic agents on the oxygen consumption of brain in vitro. Proc. Soc. Exp. Biol. Med. 1948; 69(3)566–60
  • Scott C.C., Chen K.K. The action of 1,1-diphenyl-1-(dimethylaminoiso-propyl)-butanone-2, a potent analgesic agent. J. Pharmacol. Exper. Therap. 1946; 87: 63
  • Scott C.C., Kohlstaedt K.G., Chen K.K. Comparison of the pharmacologic properties of some new analgesic substances. Anesth. & Analg. 1947; 26: 12
  • Scott C.C., Robbins E.B., Chen K.K. Pharmacologic comparison of the optical isomers of methadon. J. Pharmacol. Exper. Therap. 1948; 93: 282
  • Scott C.C., et al. Further observations on the pharmacology of Dolophine. Fed. Proc. 1947; 6: 370
  • Scott M.E., Orr R. Effects of diamorphine, methadone, morphine, and pentazocine in patients with suspected acute mycardial infarction. Lancet 1969; 1(7605)1065–67
  • Scott W.W., et al. Early clinical experience with Dolophine (No. 10820). Anesth. & Analg. 1947; 26: 18
  • Seevers M.H. Animal experimentation in studying addiction to the newer synthetic analgesics. Ann. New York Acad. Sci. 1948; 51(1)98–107
  • Shamoian C.A., Shapiro A.K. Abuse of an euphoretic combination. J.A.M.A. 1969; 207(10)1919
  • Shemano I., Wendel H. A rapid screening test for potential addiction liability of new analgesic agents. Toxicol. & Appl. Pharm. 1964; 6: 334
  • Sherrod T.R., et al. Methadone derivatives of pharmacological interest. Fed. Proc. 1948; 7: 255
  • Shideman F.E., Johnson H.T. Acute vascular tolerance to morphine, Demerol, and 1,1-diphenyl-1-(dimetliylamino-isopropyl)butanone-2 (amidone) in the dog. Fed. Proc. 1948; 7: 371
  • Shideman F.E., Johnson H.T. Acute vascular tolerance to morphine, isonipecaine (Demerol) and methadon (amidone) in the dog. J. Pharmacol. Exper. Therap. 1948; 92(4)414–20
  • Simionovici M., Winter D. L'antagonisme de la morphine a legard de certains phenomenes centraux reserpiniques. Therapie 1964; 19(4)991–95
  • Sinitsin L.N. Effect of morphine and other analgesics on brain evoked potentials. Int. J. Neuropharmacol. 1964; 3(3)321–26
  • Smith A.A., Karmin M., Gavitt J. Tolerance to the lenticular effects of opiates. J. Pharmacol. Exper. Therap. 1967; 156(1)85–91
  • Smith C.C., Lehman E.G. Analgesics. I. Effects of analgesic combinations on reaction time in rats. J. Pharmacol. 1953; 108(3)336–39
  • Smits S.E., Takemori A.E. Quantitative studies on the antagonism by naloxone of some narcotic and narcotic-antagonist analgesics. Brit. J. Pharmacol. July, 1970; 39: 627–38
  • Smits S.E., Takemori A.E. Studies on the anti-writhing analgesic receptors in mice. Pharmacologist 1969; 11(2)257
  • Sollmann T. A Manual of Pharmacology and Its Application to Therapeutics and Toxicology Eighth edition. W.B. Saunders Company, Philadelphia 1964; 282–283
  • Stern R. The pregnant addict. Amer. J. Obstet. & Gynec. 1966; 994(2)253
  • Sung C., Way E.L. The effect of the liver on the metabolism of d,l-methadone in vitro and in vivo. J. Pharmacol. Exper. Therap. 1950; 98(1)72
  • Swerdlow M. General analgesics used in pain relief: Pharmacology. Brit. J. Anaesth. 1967; 39(9)699–712
  • TLC: Growing clinical use. Lab. Management July, 1969; 7: 27
  • Taber R.I., et al. Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice. J. Pharmacol. Exper. Therap. 1969; 169(1)29–38
  • Taber R.I., Greenhouse D.D., Irwin S. Interactions between narcotic- analgesics, antagonists and other drugs on chemically-induced writhing in mice. Pharmacologist 1965; 7(2)164
  • Tainter M.L., Buchanan O.H. A comparison of certain actions of Demerol and methadone. California Med. 1949; 70(1)35–43
  • Takemori A.E. Cross-cellular adaptation to methadone and meperidine in cerebral cortical slices from morphinized rats. J. Pharmacol. Exper. Therap. 1962; 135(2)252–55
  • Tarlington M.J.K. Peritoneal dialysis in a country district hospital. Med. J. Austr. 1969; 1(25)1293–96
  • Tenen S.S. Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor. Psychophannacologia 1968; 12(4)278–85
  • Thompson W.J., Walton R.P. Elevation of plasma histamine levels in the dog following administration of muscle relaxants, opiates, and macromolecular polymers. J. Pharmacol. Exper. Therap. 1964; 143: 131
  • Thorp R.H. The pharmacology of the optical isomers of amidone (2-dimethyl-amino-4 : 4-diphenylheptan-5-one). Brit. J. Pharmacol. & Chemo. 1949; 4(1)98–104
  • Thorp R.H., et al. Optical isomers of amidone with a note on isoamidone. Nature 1947; 160–605
  • Tomlinson K.A., Kay P.G. Methadone hydrochloride (Physeptone)-a case of idiosyncrasy. Brit. Med. J. 1966; 2(5520)1007
  • Troxil E.B. Clinical evaluation of the analgesic methadon. J.A.M.A. 1948; 135: 920
  • Uchiyama J., Kirchhof A.C., David N.A. Spasmolytic action of Dolophine. Proc. Soc. Exper. Biol. & Med. 1947; 66: 417
  • Vallve C. Die Wirkung von Spasmolytica auf die mechanische und elektrische Aktivitaet des isolierten Rattenuterus. Arzneim. Forsch. 1967; 17(7)882–85
  • Van Sloten M., Kinohi R.G., Irwin S. Drug effects on the foot shock-induced behavior of paired mice. West. Pharmacol. Soc. 1968; 11: 46
  • Veatch R.M., Adler T.K., Way E.L. The importance of steric configuration in certain morphinemimetic actions of synthetic analgetics. J. Pharmacol. Exper. Therap. 1964; 145(1)11–19
  • Vessman J. Gas chromatography of high-boiling amines. Acta Pharm. Succica 1964; 1: 183
  • Vogel V.H. The treatment of drug addiction. J.A.M.A. November 8, 1965; 194(6)210
  • Vollum D.I. Skin lesions in drug addicts. Brit. Med. J. June 13, 1970; 1: 647
  • Wallach B.C., Jerez E., Blinick G. Pregnancy and menstural function in narcotics addicts treated with methadone. The methadone maintenance treatment program. Amer. J. Obstet. & Gynec. 1969; 105(8)1226–29
  • Wallenstein S.L., Beaver W.T., Houde R.W. Clinical analgesic studies of methadone utilizing both complete and incomplete block crossover designs. Pharmacologist 1966; 8(2)207
  • Walter A.J. Possible hepatotoxic effect of methadone. Canad. Med. Assoc. J. 1969; 100: 265
  • Way E.L. Detection of narcotic usage by the pupillary method. Psychopharmacol. Service Center Bull. 1966; 3(4)61–62
  • Way E.L., Adler T.K. The pharmacologic implications of the fate of morphine and its surrogates. Pharmac. Rev. edition 12. 1960; 383–446
  • Way EX., Sung C.Y., McKelway W.P. The absorption, distribution and excretion of d l methadone. J. Pharmacol. Exper. Therap. 1949; 97(2)222–28
  • Weinstock M. The role of the sympathetic nervous system in mediating the action of analgesic drugs on the lens. Arch. Pharmakol. Exp. Pathol. 1968; 259(2)201–02
  • Weinstock M., Marshall A.S. The influence of the sympathetic nervous system of the action of drugs on the lens. J. Pharmacol. Exper. Therap. 1969; 166(1)8–13
  • Whitman G.B. Man Alive is alive and well. John Hopkins Hospital Alumnae Magazine 1970; 69(1)8
  • Wieland W.F., Chambers C.D. Methadone maintenance: A comparison of two stabilization techniques. Internat. J. Addict. 1970; 5(4)645–660
  • Wieland W.F. Methadone maintenance treatment of chronic narcotic addiction. New Physician 1969; 18: 210–11
  • Wikler A., Altschul S. Effects of methadone and morphine on the electroencephalogram of the dog. J. Pharmacol. 1950; 98(4)437–46
  • Wikler A., Frank K. Hindlimb reflexes of chronic spinal dogs during cycles of addiction to morphine and methadon. J. Pharmacol. Exper. Therap. 1948; 94: 4, 382
  • Wikler A., Frank K. Tolerance and physical dependence in intact and chronic spinal dogs during addiction to 10820 (4-4-diphenyl-6-dimethylamino-heptanone-3). Fed. Proc. 1947; 6: 382
  • Williams E.M.V., Streeten D.H.P. The action of morphine, pethidine and amidone upon the intestinal motility of conscious dogs. Brit. J. Pharmacol. 1950; 5(4)584–603
  • Williams H.R., Moy W., Johnston W. Low and high methadone maintenance in out-patient treatment of the heroin addict. Internal. J. Addict. 1970; 5(4)637–644
  • Woods L.A., Wyngaarden J.B., Seevers M.H. Addiction potential- ities of 1,1-diphenyl-1-(-dimethylamino-propyl)-butanone-2 hydrochloride (Amidone) in the monkey. Proc Soc. Exper. Biol. Med. 1947; 65(1)113–14
  • Woods L.A., et al. The addiction potentialities of l,l-diphenyl-l-(dimethyl- aminoisopropyl)-butanone-2(amidone) in the monkey. Fed. Proc. 1947; 7: 387
  • World Health Organization. Technical Report Series No. 343, 1966; 9, (Section 6)
  • World Health Organization Expert Committee on Dependence-Producing Drugs. Bull. Narcotics January-March, 1967; 19(1)29–32, Fifteenth Report
  • world Health Organization Expert Committee on Drug Dependence. Technical Report Series No. 407, 1969; 1–28
  • Zaks A.M., et al. Intravenous diacetylmorphine (heroin) in studies of opiate dependence. Dis. Nerv. Syst. 1969; 30(Supplement 2)89–92

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.